Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1
暂无分享,去创建一个
Roland Rad | Allan Bradley | Ge Guo | Wei Wang | Lia S. Campos | Pentao Liu | Hui Liu | A. Bradley | R. Rad | P. Liu | Hui Liu | Z. Zenonos | Jian Yang | G. Guo | Xiongfeng Chen | Jian Yang | Dong Lu | Xiongfeng Chen | Zenon Zenonos | Shujun Zhang | Wei Wang | D. Lu | Shujun Zhang | Pentao Liu
[1] S. Cole,et al. Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .
[2] Austin G Smith,et al. A PiggyBac-Based Recessive Screening Method to Identify Pluripotency Regulators , 2011, PloS one.
[3] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[4] A. Cooney,et al. Canonical Wnt/β-Catenin Regulation of Liver Receptor Homolog-1 Mediates Pluripotency Gene Expression , 2010, Stem cells.
[5] Austin G Smith,et al. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency , 2010, Development.
[6] J. Wrana,et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. , 2010, Cell stem cell.
[7] Jialiang Liang,et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. , 2010, Cell stem cell.
[8] Hsu-hsin Chen,et al. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. , 2010, Cell stem cell.
[9] C. Lengner,et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs , 2010, Proceedings of the National Academy of Sciences.
[10] Yuriy L Orlov,et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. , 2010, Cell stem cell.
[11] Sarah L Vowler,et al. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. , 2010, Genes & development.
[12] J. Gurdon,et al. Efficiencies and mechanisms of nuclear reprogramming. , 2010, Cold Spring Harbor symposia on quantitative biology.
[13] K. White,et al. Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer , 2009, Cell.
[14] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[15] Wei Wang,et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.
[16] Paul Pavlidis,et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. , 2009, Cell stem cell.
[17] J. Nichols,et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency , 2009, Development.
[18] A. Bradley,et al. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon , 2009, Nature Methods.
[19] K. Hochedlinger,et al. Epigenetic reprogramming and induced pluripotency , 2009, Development.
[20] Sheng Ding,et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. , 2009, Cell stem cell.
[21] Hsu-hsin Chen,et al. The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells , 2008, Cell.
[22] Jennifer Nichols,et al. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.
[23] David G. Melvin,et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.
[24] P. Dollé,et al. Retinoic acid in development: towards an integrated view , 2008, Nature Reviews Genetics.
[25] B. Doble,et al. The ground state of embryonic stem cell self-renewal , 2008, Nature.
[26] M. Pellegrini,et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations , 2008, Proceedings of the National Academy of Sciences.
[27] K. Hochedlinger,et al. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. , 2008, Cell stem cell.
[28] R. Young,et al. Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.
[29] George Q. Daley,et al. Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.
[30] Takashi Aoi,et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.
[31] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[32] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[33] H. Do,et al. Transcriptional regulation of human Oct4 by steroidogenic factor‐1 , 2007, Journal of cellular biochemistry.
[34] T. Ichisaka,et al. Generation of germline-competent induced pluripotent stem cells , 2007, Nature.
[35] R. Jaenisch,et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.
[36] R. McKay,et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.
[37] M. Trotter,et al. Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.
[38] H. Schöler,et al. Erasure of Cellular Memory by Fusion with Pluripotent Cells , 2007, Stem cells.
[39] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[40] H. Schöler,et al. Variable Reprogramming of the Pluripotent Stem Cell Marker Oct4 in Mouse Clones: Distinct Developmental Potentials in Different Culture Environments , 2005, Stem cells.
[41] K. Akashi,et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice , 2005 .
[42] K. Akashi,et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. , 2005, Blood.
[43] J. Thomson,et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast , 2002, Nature Biotechnology.
[44] H. Schöler,et al. Oct4 distribution and level in mouse clones: consequences for pluripotency. , 2002, Genes & development.
[45] Y. Bergman,et al. Synergy of SF1 and RAR in Activation of Oct-3/4Promoter* , 2000, The Journal of Biological Chemistry.
[46] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[47] Y. Bergman,et al. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells , 1995, Molecular and cellular biology.
[48] H. Schöler,et al. Regulation of the Oct-4 gene by nuclear receptors. , 1994, Nucleic acids research.
[49] Y. Bergman,et al. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region , 1994, Molecular and cellular biology.
[50] S. Garattini,et al. Effects of synthetic retinoids and retinoic acid isomers on the expression of alkaline phosphatase in F9 teratocarcinoma cells. , 1993, Biochemical and biophysical research communications.
[51] R. Evans,et al. A mutated retinoic acid receptor-alpha exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. , 1992, Genes & development.